While Hims & Hers Health Inc has overperformed by 1.99%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HIMS rose by 227.59%, with highs and lows ranging from $35.02 to $8.09, whereas the simple moving average jumped by 45.17% in the last 200 days.
On December 17, 2024, Morgan Stanley started tracking Hims & Hers Health Inc (NYSE: HIMS) recommending Overweight. A report published by BofA Securities on November 14, 2024, Downgraded its rating to ‘Underperform’ for HIMS. Needham also rated HIMS shares as ‘Buy’, setting a target price of $24 on the company’s shares in an initiating report dated August 22, 2024. Citigroup May 22, 2024d its ‘Buy’ rating to ‘Neutral’ for HIMS, as published in its report on May 22, 2024. Jefferies’s report from April 16, 2024 suggests a price prediction of $15 for HIMS shares, giving the stock a ‘Hold’ rating. Canaccord Genuity also rated the stock as ‘Buy’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Hims & Hers Health Inc (HIMS)
Further, the quarter-over-quarter increase in sales is 77.13%, showing a positive trend in the upcoming months.
One of the most important indicators of Hims & Hers Health Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 26.35% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.82, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and HIMS is recording 16.76M average volume. On a monthly basis, the volatility of the stock is set at 9.62%, whereas on a weekly basis, it is put at 8.28%, with a loss of -9.58% over the past seven days. Furthermore, long-term investors anticipate a median target price of $27.86, showing decline from the present price of $28.15, which can serve as yet another indication of whether HIMS is worth investing in or should be passed over.
How Do You Analyze Hims & Hers Health Inc Shares?
The Household & Personal Products market is dominated by Hims & Hers Health Inc (HIMS) based in the USA. When comparing Hims & Hers Health Inc shares with other companies under Consumer Defensive, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 65.12, there is a growth in quarterly earnings of 993.33%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 18.80%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 56.00% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
HIMS shares are owned by institutional investors to the tune of 56.00% at present.
